Literature DB >> 12606546

Transcription cooperation by NFAT.C/EBP composite enhancer complex.

Teddy T C Yang1, Chi-Wing Chow.   

Abstract

The nuclear factor of activated T cells (NFAT) group of transcription factors regulates gene expression in immune and non-immune cells. NFAT-mediated gene transcription is orchestrated, in part, by formation of a composite regulatory element. Here we demonstrate that NFAT interacts with transcription factor CCAAT/enhancer-binding protein (C/EBP) to form a composite enhancer complex, to potentiate expression of the peroxisome proliferator-activated receptor-gamma2 gene. Formation of a ternary NFAT.C/EBP.DNA complex is required for the transcriptional cooperation. A similar NFAT.C/EBP composite element is found in the regulatory region of the insulin-like growth factor 2, angiotensin-converting enzyme homolog, and transcription factor POU4F3 genes. Thus, the NFAT.C/EBP composite element represents a novel regulatory enhancer to direct NFAT-mediated gene transcription.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12606546     DOI: 10.1074/jbc.M211560200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells.

Authors:  Maria Alejandra Alfonso-Jaume; Rajeev Mahimkar; David H Lovett
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

Review 2.  Structure-function relationships in the IL-17 receptor: implications for signal transduction and therapy.

Authors:  Fang Shen; Sarah L Gaffen
Journal:  Cytokine       Date:  2008-01-04       Impact factor: 3.861

3.  Misexpression of CCAAT/enhancer binding protein beta causes osteopenia.

Authors:  Stefano Zanotti; Lisa Stadmeyer; Anna Smerdel-Ramoya; Deena Durant; Ernesto Canalis
Journal:  J Endocrinol       Date:  2009-02-13       Impact factor: 4.286

4.  Role of TH-17 cells in rheumatic and other autoimmune diseases.

Authors:  Michael V Volin; Shiva Shahrara
Journal:  Rheumatology (Sunnyvale)       Date:  2011-10-20

5.  Myeloid-Derived Suppressor Cells Ameliorate Cyclosporine A-Induced Hypertension in Mice.

Authors:  Valorie L Chiasson; Kelsey R Bounds; Piyali Chatterjee; Lochana Manandhar; Abhinandan R Pakanati; Marcos Hernandez; Bilal Aziz; Brett M Mitchell
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

6.  Lipin 1 represses NFATc4 transcriptional activity in adipocytes to inhibit secretion of inflammatory factors.

Authors:  Hyun Bae Kim; Anil Kumar; Lifu Wang; Guang-Hui Liu; Susanna R Keller; John C Lawrence; Brian N Finck; Thurl E Harris
Journal:  Mol Cell Biol       Date:  2010-04-12       Impact factor: 4.272

7.  Involvement of nuclear factor of activated T cells 3 (NFAT3) in cyclin D1 induction by B[a]PDE or B[a]PDE and ionizing radiation in mouse epidermal Cl 41 cells.

Authors:  Jin Ding; Ronghe Zhang; Jingxia Li; Caifang Xue; Chuanshu Huang
Journal:  Mol Cell Biochem       Date:  2006-04-28       Impact factor: 3.396

8.  Recruitment of the extracellular signal-regulated kinase/ribosomal S6 kinase signaling pathway to the NFATc4 transcription activation complex.

Authors:  Teddy T C Yang; Qiufang Xiong; Isabella A Graef; Gerald R Crabtree; Chi-Wing Chow
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

9.  Nuclear factor of activated T-cells isoform c4 (NFATc4/NFAT3) as a mediator of antiapoptotic transcription in NMDA receptor-stimulated cortical neurons.

Authors:  Aruna Vashishta; Agata Habas; Priit Pruunsild; Jing-Juan Zheng; Tõnis Timmusk; Michal Hetman
Journal:  J Neurosci       Date:  2009-12-02       Impact factor: 6.167

10.  Identification of interacting transcription factors regulating tissue gene expression in human.

Authors:  Zihua Hu; Steven M Gallo
Journal:  BMC Genomics       Date:  2010-01-19       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.